Weiss Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Weiss Asset Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13,500	Closed	-$1.02M	–	792
2022 Q2	$1.02M	Buy	+13,500	New	+$600K	0.02%	438

Weiss Asset Management's TPTX Position: Q3 2022 in Review

Weiss Asset Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 13,500 shares — an estimated $1.02M sold.

Weiss Asset Management first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $1.02M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Weiss Asset Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Weiss Asset Management sold 13,500 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.02M.
Weiss Asset Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Weiss Asset Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.02M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Weiss Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.